Skyrizi 360 mg
Skyrizi 360 mg is a medicine authorised by Swissmedic under authorisation number 68946. The authorisation holder is AbbVie AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 September 2023 and the authorisation is limited until 13 September 2028. ATC code L04AC18 places the medicine in the group Immunosuppressants.
| Authorisation number | 68946 |
|---|---|
| Name | Skyrizi 360 mg |
| Full name | Skyrizi 360 mg, Injektionslösung in einer Patrone für ein Dosiergerät |
| Authorisation holder | AbbVie AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC18 |
| First authorisation | 14 September 2023 |
| Authorisation validity | 13 September 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Skyrizi 360 mg, Injektionslösung in einer Patrone für ein Dosiergerät | B | 14 September 2023 |
| 2 | Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät | B | 14 February 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Stück | L04AC18 | 07.15.0. | B |
| 2 | 1 | Stück | L04AC18 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Skyrizi 360 mg authorised in Switzerland?
Yes. Skyrizi 360 mg is authorised by Swissmedic under authorisation number 68946, data as of 01 September 2026. The authorisation is limited until 13 September 2028.
Which dispensing category does Skyrizi 360 mg have?
Skyrizi 360 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Skyrizi 360 mg?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.